Ozempic and its weight-loss cousin, Wegovy, outperform an earlier drug targeting the same gut hormone, a new study shows Ozempic produced 10% or more weight loss in 61% of obese people compared with ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The ...

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

For nearly 3,400 patients with obesity, the average weight loss achieved with semaglutide (Wegovy and Ozempic) was more than twice that achieved with liraglutide (Saxenda and Victoza). Cleveland ...

The World Health Organization has released new guidance on some weight loss medications for adults with obesity.

Researchers report that more than half of people on weight loss drugs Wegovy and Saxenda stop taking them at 12 weeks or earlier. They said that 30% of people on the drugs stop using them within the ...

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

In the ever-evolving symphony of weight loss medications, Saxenda (Liraglutide) has long taken center stage as a virtuoso in pharmaceutical solutions for shedding unwanted pounds. Yet, the search for ...